VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer

CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer

CheckMate 067: Nivolumab plus ipilimumab combination therapy in advanced melanoma

IMspire170: New combination treatment for advanced melanoma

ARIEL3: Rucaparib maintenance treatment for recurrent ovarian carcinoma

Checkmate 227: Final analysis for the non small cell lung cancer trial

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma

KATHERINE trial updates for HER2-positive breast cancer

PARP inhibitors for metastatic breast cancer

TRITON2: Rucaparib for metastatic castration-resistant prostate cancer

Lutetium-177 PSMA scanning for prostate cancer